Epsilon M&A Deal Report - Actavis Generics Commercial Operations In Euro Zone Markets
Transaction Multiples for the Valuation of Private Companies
Aurobindo Pharma / Actavis Generics Commercial Operations In Euro Zone Markets
No EMAT :
62880
Announced Date :
17/01/2014
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Aurobindo Pharma
Target :
Actavis Generics Commercial Operations In Euro Zone Markets
Country :
France
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Actavis Generics Commercial Operations provide a broad Western-European pharmaceuticals platform including personnel, commercial infrastructure, products, marketing authorizations and dossier...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
ns |
|
||||
| Current |
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 19/05/2011 | STADA Arzneimittel | Spirig Healthcare | Switzerland | ** | 62850 |
| 03/02/2014 | Private Group led by IDI | Winncare | France | * | 62374 |
Source: Epsilon Research / EMAT
